Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of pulmonary fibrosis and drugs, applied in the field of drugs for the treatment of pulmonary fibrosis, can solve problems that are difficult to completely treat diseases with complex pathogenesis
Active Publication Date: 2020-05-29
GUANGXI UNIV OF CHINESE MEDICINE
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The effect of single traditional Chinese medicine on pulmonary fibrosis is limited, and it is difficult to completely treat diseases with complex pathogenesis. Chinese medicine compound is the most difficult point of Chinese medicine research
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Example 1: The Intervention Effect of Hamangfeixian Recipe on Pulmonary Fibrosis Model Mice
[0018] 1 Experimental materials
[0019] 1.1 Experimental animals
[0020] About 18-22g Kunming SPF grade male mice, certificate number: scxkgui 2009-0002, provided by the Experimental Animal Center of Guangxi Medical University.
[0021] 1.2 Drugs and reagents
[0022] Dexamethasone sodium phosphate injection (1ml, 5mg, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., production batch number: 130608); bleomycin hydrochloride for injection (Nippon Kayaku Co., Ltd., product batch number: 120901); gecko (Guangxi Yulin Shenbaotang Chinese Herbal Pieces Co., Ltd., product batch number: 130802); Wuzhi milk (Guangxi Yulin Shenbaotang Chinese Herbal Pieces Co., Ltd., product batch number: 130905); mango leaves (self-collected, identified by Qin Wenhui, Department of Chinese Medicine, Guangxi University of Traditional Chinese Medicine ); Panax notoginseng (Guangxi Yulin Shenba...
Embodiment 2
[0069] Example 2: Interventional effect of Hamangfeixian recipe on inflammation of human bronchial epithelial cells (BEAS-2B)
[0074] Feixianfang, composed of Gecko, Wuzhi milk, mango leaves, yellow root and Panax notoginseng, was extracted and prepared by Tianjin Institute of Pharmaceutical Sciences; 1640 basal medium (HyClone, USA); double antibodies (ampicillin and streptomycin) , fetal bovine serum, trypsin (Gibco, USA); TNF-α (Peprotech, USA); dexamethasone (Dex, Sigma, USA); PGL4.32 plasmid and Renilla luciferase plasmid, cell lysate, double Luciferase re...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicine for treating pulmonary fibrosis. The medicine for treating the pulmonary fibrosis is characterized in that the medicine prescription consists of traditional Chinese medicine gecko, ficus hirta, mango leaves, prismatomeria tetrandra and panax notoginseng. In the prescription, the gecko and the ficus hirta serve as medicines for reinforcing deficiency and strengthening body resistance, the mango leaves serve as medicines for diminishing inflammation, relieving cough and reducing phlegm, and the prismatomeria tetrandra and the panax notoginseng serve as medicines for removing blood stasis and eliminating stagnation. The prescription realizes reasonable medicine use according to the traditional Chinese medicine thought about treatment based on syndrome differentiation so as to achieve the effect of treating both symptoms and root causes. Experimental research proves the effectiveness and the action mechanism of the prescription on the pulmonary fibrosis, and the prescription can be applied to novel traditional Chinese medicines for developing and treating the pulmonary fibrosis.
Description
technical field [0001] The invention belongs to the technical field of pulmonary fibrosis treatment, in particular to a medicine for treating pulmonary fibrosis. Background technique [0002] Pulmonary fibrosis (PF) is a type of disease in which diffuse exudation, infiltration and fibrosis of the pulmonary interstitium are the main lesions. Its main symptoms include dyspnea, shortness of breath, dry cough, and wheezing. die. At present, its pathogenesis is still unclear, and with the continuous deterioration of environmental pollution, the incidence rate is increasing year by year. At present, Western medicine mainly uses hormones and immunosuppressant drugs for the traditional treatment of pulmonary fibrosis, but the curative effect is not ideal and there are side effects. There is no disease name for pulmonary fibrosis in TCM literature. According to its symptoms, it can be classified as "pulmonary obstruction", "lung impotence", "cough", etc. Clinical and practice shows...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more